TABLE 3.
Incidences of adverse effects.
| Glucoraphanin group (n = 38) | Placebo group (n = 38) | P-value | |
| Side effects | 0 (0%) | 0 (0%) | N.A. |
| Adverse events | 2 (5.3%) | 8 (21.1%) | 0.086 |
Data are shown as number (percentage).
P-values were determined using the chi-squared test.
N.A., not available.